Bristol, Lilly Blockbuster Drugs Targeted by Biden for Medicare Price Cuts
President Joe Biden said his historic foray into negotiating prices with Bristol-Myers Squibb Co., Johnson & Johnson and other drugmakers is just the start, vowing to see it through despite fierce industry pushback.









